Royalty Pharma Income Statement (2019-2026) | RPRX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
585.77M575.70M562.05M535.96M573.46M565.75M683.97M538.20M536.31M596.07M567.98M537.27M564.69M593.64M568.25M578.66M609.29M621.99M630.58M674.14M
Operating items
Amortization - Intangibles (Quarter)
5.80M5.80M5.67M
Research & Development (Quarter)
90.50M103.78M100.50M0.61M25.50M50.49M0.50M0.50M50.50M0.50M0.50M0.50M0.50M0.50M50.50M250.00M50.50M50.50M39.80M97.90M
Selling, General & Administrative (Quarter)
48.59M46.16M51.54M51.84M50.69M73.23M85.69M47.63M57.23M59.19M57.65M54.71M56.72M67.59M110.70M179.77M118.73M164.27M159.49M161.89M
Other Operating Expenses (Quarter)
143.63M272.34M190.29M105.71M305.06M924.68M118.80M241.23M277.14M-76.51M583.60M212.43M-227.60M164.04M-127.14M-60.90M12.90M18.84M-131.75M281.24M
Operating Expenses (Quarter)
282.72M422.28M342.33M158.16M381.25M1,048.40M205.00M289.36M384.87M-16.83M641.75M267.64M-170.38M232.13M34.06M368.87M182.13M233.61M67.54M541.02M
Operating Income (Quarter)
303.05M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M388.38M563.04M133.12M
EBIT (Quarter)
303.05M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M388.38M563.04M133.12M
Non-operating items
Non Operating Investment Income (Quarter)
11.76M
Interest & Investment Income (Quarter)
12.26M10.64M9.53M10.92M14.03M43.85M16.70M25.65M23.44M6.50M7.42M13.38M17.51M9.04M11.29M8.33M6.90M7.07M6.23M5.13M
Other Non Operating Income (Quarter)
-16.97M15.76M-1.03M-10.80M-112.34M-2.81M1.09M-1.71M6.00M-1.65M-9.00M-3.06M-2.00M-1.57M-15.35M-2.20M-1.50M
Non Operating Income (Quarter)
-81.26M-99.75M-91.64M113.81M28.20M-127.38M30.12M102.50M-29.36M104.69M69.50M-75.25M71.28M-27.16M-99.75M-119.16M17.05M-32.47M-94.78M-51.63M
Net income details
EBT (Quarter)
221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M434.43M90.64M444.21M355.91M468.26M81.49M
Profit After Tax (Quarter)
221.80M7.90M128.08M491.60M142.65M-268.85M509.09M227.62M72.11M1,059.59M4.78M185.33M806.36M208.21M239.35M90.64M444.21M-197.33M294.69M81.49M
Income from Non-Controlling Interests (Quarter)
119.87M45.77M76.32M187.09M77.76M-153.95M168.33M123.71M49.96M223.25M-9.05M92.37M262.37M126.14M195.08M19.70M155.99M141.71M173.57M63.60M
Income from Continuing Operations (Quarter)
221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M434.43M90.64M444.21M355.91M468.26M81.49M
Consolidated Net Income (Quarter)
221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M434.43M90.64M444.21M355.91M468.26M81.49M
Income towards Parent Company (Quarter)
221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M434.43M90.64M444.21M355.91M468.26M81.49M
Net Income towards Common Stockholders (Quarter)
221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M434.43M90.64M444.21M355.91M468.26M81.49M
Additional items
EPS (Basic) (Quarter)
0.520.130.301.130.50-1.391.140.780.271.60-0.010.431.800.751.000.211.030.831.070.18
EPS (Diluted) (Quarter)
0.370.130.210.810.36-1.390.840.580.201.19-0.010.331.360.560.750.160.790.630.840.15
Shares Outstanding (Quarter)
428.23M414.79M433.96M436.32M439.29M437.96M445.61M450.40M448.44M447.60M448.62M451.02M447.63M448.19M435.48M423.51M431.89M429.80M436.79M445.06M
Shares Outstanding (Diluted) (Quarter)
607.17M414.80M607.20M607.21M607.23M437.97M607.25M605.86M601.14M602.90M597.48M596.91M592.73M594.11M578.10M562.30M559.61M564.46M556.84M556.90M
Shares Outstanding (Entity) (Quarter)
429.51M432.96M435.32M437.14M441.10M443.17M448.29M450.35M445.84M446.69M450.98M449.06M446.04M445.99M425.59M432.29M429.03M428.67M443.63M445.75M
EBITDA (Quarter)
303.05M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M388.38M563.04M133.12M
Interest Expenses (Quarter)
-209.30M46.97M-198.90M-193.80M-188.70M0.66M178.60M173.60M168.80M29.24M160.60M205.20M192.60M-0.18M182.50M177.50M79.56M38.05M223.60M218.10M